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ABSTRACT We report the effects of ligand presentation on the binding of aqueous proteins to solid supported lipid bilayers.
Speciﬁcally, we show that the equilibrium dissociation constant can be strongly affected by ligand lipophilicity and linker length/
structure. The apparent equilibrium dissociation constants (KD) were compared for two model systems, biotin/anti-biotin and
2,4-dinitrophenyl (DNP)/anti-DNP, in bulk solution and at model membrane surfaces. The binding constants in solution were
obtained from ﬂuorescence anisotropy measurements. The surface binding constants were determined by microﬂuidic tech-
niques in conjunction with total internal reﬂection ﬂuorescence microscopy. The results showed that the bulk solution equi-
librium dissociation constants for anti-biotin and anti-DNP were almost identical, KD(bulk) ¼ 1.7 6 0.2 nM vs. 2.9 6 0.1 nM. By
contrast, the dissociation constant for anti-biotin antibody was three orders of magnitude tighter than for anti-DNP at a lipid
membrane interface, KD ¼ 3.6 6 1.1 nM vs. 2.0 6 0.2 mM. We postulate that the pronounced difference in surface binding
constants for these two similar antibodies is due to differences in the ligands’ relative lipophilicity, i.e., the more hydrophobic DNP
molecules had a stronger interaction with the lipid bilayers, rendering them less available to incoming anti-DNP antibodies compared
with the biotin/anti-biotin system. However, when membrane-bound biotin ligands were well screened by a poly(ethylene glycol)
(PEG) polymer brush, the KD value for the anti-biotin antibody could also be weakened by three orders of magnitude, 2.4 6
1.1 mM. On the other hand, the dissociation constant for anti-DNP antibodies at a lipid interface could be signiﬁcantly enhanced
when DNP haptens were tethered to the end of very long hydrophilic PEG lipopolymers (KD ¼ 216 10 nM) rather than presented
on short lipid-conjugated tethers. These results demonstrate that ligand presentation strongly inﬂuences protein interactions with
membrane-bound ligands.
INTRODUCTION
Interactions which occur between proteins and ligands are
ubiquitous in biological recognition (1–4). Many drug mol-
ecules function by disrupting these interactions, especially by
binding to proteins at membrane interfaces (5,6). Curiously,
the equilibrium dissociation constants for drugs with mem-
brane proteins in vivo are often only in the micromolar range
(7,8). This is the case despite the fact that many of these in-
teractions are nanomolar or even picomolar when originally
screened in vitro in the absence of a lipid bilayer. There is
some evidence in the literature that the partitioning of drug
molecules into lipid membranes occurs via lipophilic inter-
actions (7,9,10). It certainly is possible that such interactions
as well as interactions with the cell’s glycocalix are respon-
sible for suppressing KD values for drug molecules in vivo.
Therefore, we wished to test the binding afﬁnity of ligand-
receptor interactions for model binding systems at membrane
surfaces as well as in bulk solution to see if lipophilicity and
steric effects could modulate the binding constants of simple
antibody-antigen systems.
The speciﬁc binding of antibodies with their target antigens
at cell surfaces is a key step in immune response (11,12). The
recognition of membrane-conjugated haptens by free protein
molecules is, in contrast to solution recognition, complicated
by the presence of the cell membrane interface (13). Previous
studies have shown that binding between immunoglobulin G
(IgG) molecules and antigens bound in the membrane de-
pends upon the speciﬁc conditions of the experiment. For
example, the McConnell group reported qualitative data
which indicated that the binding of anti-DNP antibodies with
DNP-conjugated lipid haptens was reduced above the chain-
melting transition temperature of a lipid bilayer compared to
the same system in the gel state (14,15). The authors sug-
gested that the DNP moieties can interact with the interior of
the ﬂuid lipid bilayers. Additionally, poly(ethylene glycol)
(PEG)-modiﬁed lipid membranes are believed to decrease the
efﬁciency of the ligand-receptor recognition processes.
Kim et al. (16) andMoore and Kuhl (17) have reported that
the adhesion strength of ligand-protein interactions depends
on the ligand accessibility within the PEG layer. Dori and co-
workers demonstrated that cell adhesion to peptide ligands in
a supported bilayer can be controlled by the addition of PEG-
conjugated lipids to the membrane (18). Such effects can be
desirable. In fact, PEG-conjugated liposome surfaces have
been shown to have long circulation times in vivo (19,20).
The extracellular PEG layer is generally believed to stabilize
the liposome surface via steric repulsion effects (21,22).
PEG moieties can also be used to enhance binding rather
than inhibit it. For example, target molecules are often teth-
ered to the terminal end of a PEG chain for site-speciﬁc li-
posome drug delivery (23–25). Similarly, ligands can be
covalently linked to ﬂexible spacers or tethers on lipid bilay-
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ers. It is known that protein binding to ligands at surfaces can
be more efﬁcient via long, ﬂexible polymer tethers than via
very short ones (26–28). Such tethers may serve to orient the
ligands, which could aid in the efﬁcacy of antibody binding
depending on the relative hydrophobicity of the linker. In fact,
DNP and trinitorphenyl (TNP) haptens with sufﬁciently short
or long hydrophobic spacers are known to be less effective for
antibody binding than those with intermediate chain lengths
(29,30). Ahlers et al. (31) and Leckband et al. (13) have em-
phasized long, ﬂexible, hydrophilic ethylene oxide linkers for
improving hapten presentation at bilayer interfaces.
We report that hapten presentation for binding aqueous
IgG antibodies can be systematically manipulated depending
upon the ligand’s lipophilicity, the presence of membrane-
conjugated PEG in the membrane, and the use of PEG linkers
to conjugate the hapten. Speciﬁcally, equilibrium dissocia-
tion constants for the biotin/anti-biotin and DNP/anti-DNP
systems were examined in bulk solution and at model mem-
brane surfaces. Solution binding constants were determined
by ﬂuorescence anisotropy measurements (32–34). For sur-
face binding assays, lipid membrane-coated microﬂuidic
devices were employed in conjunction with total internal re-
ﬂection ﬂuorescence microscopy (TIRFM) (35), a method
previously established in our laboratory (36). Lipid-conjugated
haptens were incorporated into the supported lipid bilayers
(SLBs), which are well known to show speciﬁc antibody
binding and retain many of the properties of native cell mem-
branes (37). Such methods rapidly provide highly accurate
thermodynamic information while consuming relatively low
sample volumes.
The results of our experiments are summarized in Fig. 1. It
was found that anti-biotin and anti-DNP bind with their re-
spective hapten moieties in bulk solution with nearly iden-
tical afﬁnity (low nanomolarKD values). At a lipid membrane
interface, anti-biotin was still found to bind to lipid-conjugated
biotin with very strong afﬁnity. By contrast, the equilibrium
dissociation constant was greatly weakened for anti-DNP
binding to lipid-conjugated DNP on a SLB. This result can be
explained in terms of the relative lipophilicity of DNP
compared with biotin. Most of this lost afﬁnity could be re-
covered by linking the DNP moiety to the end of a PEG2000-
conjugated lipid. On the other hand, biotin/anti-biotin binding
could be weakened to micromolar afﬁnity by covering the
biotin-presenting interface under a pegylated layer. These re-
sults clearly demonstrate that interfacial binding afﬁnity can be
manipulated over a wide range of binding afﬁnities simply by
altering the nature of ligand presentation.
MATERIALS AND METHODS
Materials
Biotin-4-ﬂuorescein (B4F) was purchased from Invitrogen (Eugene, OR).
v-Hydroxyl a-amino PEG was obtained from Jenkem Technology USA
(Plano, TX). Afﬁnity puriﬁed polyclonal anti-biotin IgG from goat (lot No.
15501, Rockland, Gilbertsville, PA) and polyclonal anti-DNP IgG from goat
(lot No. A150-117A-1, Axxora, San Diego, CA) were used as received.
1-Palmitoyl-2-oleoyl-sn-glycero-3-phophocholine (POPC), 1,2-dipalmitoyl-
sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) (sodium salt) (biotin-
cap-PE), and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[6-[(2,4-
dinitrophenyl)amino]caproyl] (DNP-cap-PE) were purchased from Avanti
Polar Lipids (Alabaster, AL). 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-
N-[methoxy(poly(ethylene glycol)-5000)] (ammonium salt) (PEG5000-PE),
1,2-distearoly-sn-glycero-3-phosphoethanolamine-N-[methoxy(poly(ethylene
glycol)-2000)] (ammonium salt) (PEG2000-PE), 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[biotinyl(polyethylene glycol)-2000] (ammonium
salt) (biotin-PEG2000-PE), 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-
N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD-PE), and 1,2-
distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)-
2000] (ammonium salt) (NH2-PEG
2000-PE) were also obtained from Avanti
Polar Lipids. Three additional molecules needed for these studies, DNP
(5-ﬂuorescein) (D5F), DNP-PEG2000-PE, and DNP-PEG2000 were not com-
mercially available but could be easily synthesized as described below. Their
structures along with the one from B4F are shown in Fig. 2, A–D.
Synthesis of D5F
To prepare D5F, 5-carboxyﬂuorescein succinimidyl ester (7.1 mg in di-
methyl sulfoxide (DMSO)) was slowly added to a solution of N-(2,4-dini-
trophenyl)-cadaverine hydrochloride (4.8 mg) in 4.87 mL of sodium
bicarbonate buffer (100 mM, pH 8.3). It should be noted that this represents a
molar ratio of 1.0:1.1. An orange product formed immediately. The reaction
was allowed to proceed for 1 h at room temperature in the dark under constant
stirring. The reaction mixture was concentrated to an oil on a rotary evap-
orator and then redissolved in a CH3CN/CH3OH/H2O mixture (5:4:1 by
volume) for silica gel chromatography. The product-containing fraction was
further puriﬁed by preparative reversed phase high-performance liquid
chromatography (HPLC) and characterized by time of ﬂight mass spec-
trometry (TOF-MS). The molecular mass was found to be 626.1 Da as ex-
pected.
FIGURE 1 Schematic representation of antibody-hapten interactions. (A)
Bulk solution. (B) Binding at phospholipid membrane surfaces. The hydro-
philic biotin ligands are fully exposed to aqueous solution. By contrast, the
lipophilic DNP ligands spend more time buried in the lipid phase. (C)
Binding at PEG-coated surfaces. For the biotin case, the PEG lipopolymer
screens the ligand. On the other hand, presenting the DNP ligand on the end
of a PEG tether helps enhance binding.
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Preparation of vesicles
containing DNP-PEG2000-PE
Small unilamellar vesicles (SUVs) composed of NH2-PEG
2000-PE (1 mol
%)/PEG2000-PE (0, 4, or 9 mol %)/POPC (99, 95, or 90 mol %) as well as
NH2-PEG
2000-PE (5 mol %)/POPC (95mol %) were mixed with an excess of
6-(2,4-dinitrophenyl)aminohexanoic acid, succinimidyl ester (DNP-X, SE,
Invitrogen) in phosphate buffered saline (PBS). DNP-X was only sparingly
soluble in the PBS solution, so 100 mL of DMSO was added to the 500 mL
aqueous solution to improve solubility. This solution was stirred for 4 h at
room temperature. It should be noted that the PBS solution consisted of 20
mM Na2HPO4 and 150 mM NaCl. The pH value was adjusted to 7.2 by the
dropwise addition of NaOH. Puriﬁed water from a NANOpure Ultrapure
Water System (18.2 MVcm, Barnstead, Dubuque, IA) was employed for
making all solutions.
Product-containing SUVs were separated from unreacted DNP-X, SE by
size exclusion chromatography using standard procedures (38). The forma-
tion of DNP-PEG2000-PE was conﬁrmed by matrix-assisted laser desorption
ionization mass spectrometry (MALDI-MS). The molecular mass was found
to be 3051.5Da in H1mode. The unreacted NH2-PEG
2000-PE peak at 2788.1
Da was also found. This is not surprising because half the NH2-PEG
2000-PE
was facing inside the vesicles during the reaction and should not be available.
In fact, ;50 mol % of the NH2-PEG
2000-PE was not conjugated to DNP.
Control experiments demonstrated that NH2-PEG
2000-PE did not bind to
anti-DNP antibodies in supported membrane formats.
The mol % of DNP-PEG2000-PE in each SUV was determined by forming
supported bilayers with these lipids in POPC and performing quantitative bind-
ing measurements by introducing a saturation concentration of ﬂuorescently la-
beled IgGmolecules into the bulk phase. Such data were then directly compared
to analogous ﬂuorescence intensity results obtained with DNP-cap-PE in POPC
at known ligand concentration. These results conﬁrmed that half of the NH2-
PEG2000-PE in each vesicle was converted to DNP-PEG2000-PE as expected.
Synthesis of DNP-PEG2000
6-(2,4-Dinitrophenyl)aminohexanoic acid, succinimidyl ester (4.2 mg in
DMSO) was slowly mixed with a solution of v-hydroxyl a-amino poly-
ethylene glycol (16 mg) in sodium bicarbonate buffer (100 mM, pH 8.3). The
molar ratio was 1.2:1.0. The reaction was completed after 3 h under constant
stirring. A yellow solid product was puriﬁed by silica gel chromatography
and then characterized by MALDI-MS. The molecular mass was found to be
2329.6 Da in H1 mode.
Fluorescence anisotropy measurements
Solution binding assays were performed by single-point ﬂuorescence an-
isotropy measurements (Koala spectroﬂuorometer, ISS, Urbana-Champaign,
IL). Data were abstracted according to established procedures (34). Brieﬂy,
samples were excited with vertically polarized light at 490 nm with a slit
width of 8 nm. Emission measurements were made with both vertically, IVV,
and horizontally, IVH, polarized light. Note that the ﬁrst subscript on the
intensity term refers to the excitation polarization, and the second subscript
refers to the emission polarization. The correction factor, G, was determined
as described elsewhere (39). The ﬂuorescence anisotropy, r, was then cal-
culated as follows:
r ¼ IVV  GIVH
IVV1 2GIVH
with G ¼ IHV
IHH
:
Circulating water baths maintained the samples at a constant temperature
(25.0C 6 0.1C). Background ﬂuorescence corrections for antibody solu-
tions were performed as well as PBS blanks. In all cases the control sample
intensities were found to be ,2% of the B4F and D5F intensities.
Fabrication of microﬂuidic devices and
SLBs formation
All membrane binding assays were performed inside lipid bilayer-coated
microﬂuidic devices (40). The devices were formed by bonding patterned
polydimethylsiloxane molds onto planar glass substrates immediately after
both materials had been treated in an oxygen plasma. SLBs were formed on
the walls and ﬂoors of the microchannels by the spontaneous fusion of SUVs
from 2.5 mg/mL lipid solutions in PBS (41). The SUVs (5 mL) were injected
FIGURE 2 Structures. (A) B4F, (B)
D5F, (C) DNP-PEG2000-PE, and (D)
DNP-PEG2000.
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into the channels (both seven- and nine-channel constructs were employed)
immediately after a nascently formed microﬂuidic device had been fabri-
cated. Excess vesicles inside each channel were ﬂushed away with pure PBS
buffer. All SLBs employed in these experiments were veriﬁed to be homo-
geneous down to the optical diffraction limit under ﬂuorescence microscopy
using a 403 objective. This was even the case for ternary lipid mixtures such
as biotin-cap-PE/PEG5000-PE/POPC.
Preparation of SUVs
For the preparation of SUVs, the desired mole fractions of lipids were mixed
in chloroform, dried under a stream of dry nitrogen, and subjected to des-
iccation under vacuum for 3 h. The lipid mixtures were then hydrated in PBS.
Next, the samples were subjected to 10 freeze-thaw cycles and extruded 10
times through a polycarbonate ﬁlter with 50 nm pores.
A side-by-side comparison of the lipid composition from vesicles and the
subsequently formed lipid bilayer was made to conﬁrm that they had iden-
tical composition. This was done by MALDI-MS. The results showed that
the two compositions in bulk were the same within experimental error.
Additional controls were performed to compare the ratio of intensities of dye
(Alexa Fluor 594)-labeled PEG lipids (38) and NBD-PE in surface adsorbed
vesicles and SLBs. The relative intensity ratio of the two dyes was found to
be similar. Thus, we assumed that the concentration of hapten in the upper
leaﬂet of the bilayer was similar to its concentration in vesicles. These data
are provided in the Supplementary Material (Figs. S6 and S7).
TIRFM
Microﬂuidic assays in combination with TIRFM were used to obtain surface
binding data (40). For this purpose Alexa Fluor labels were conjugated to
the IgG molecules by standard procedures using an Invitrogen labeling
kit (A10239). Varying concentrations of antibodies were ﬂowed into
the channels at a rate of 200 nL/min until the bulk ﬂuorescence intensity from
the dye-labeled antibodies became constant as judged by epiﬂuorescence
measurements (Nikon E800 Fluorescence Microscope, Nikon, Tokyo,
Japan). This took up to 5 h at the lowest protein concentrations that were
employed. It should be noted that one important advantage of our micro-
ﬂuidic assays is that the binding data at all protein concentrations can be
monitored simultaneously as a function of time (36). Therefore, one can
monitor the binding curve’s evolution. It is typically observed that the lowest
concentration points take the longest time to achieve their ultimate values. It
should be further noted that antibody binding is reversible but requires the
presence of soluble ligand in solution to compete the antibody off the surface
in a reasonable amount of time. This has to do with rebinding effects that
have been studied by Thompson and co-workers (3,42–44).
The excitation beam for the TIRFM experiments came from a 594 nm
helium-neon laser beam (4 mW, Uniphase, Manteca, CA), which was pro-
jected onto the sample with a line generator lens (BK7 for 30, Edmund
Optics, Barrington, NJ) to create a uniform intensity proﬁle across the mi-
crochannels. It should be noted, however, that whereas the beam intensity is
uniform perpendicular to the direction of the microﬂuidic channels, the in-
tensity of the beam parallel to the channels corresponds to a Gaussian
function in intensity.
A representative ﬂuorescencemicrograph of a working device is shown in
the SupplementaryMaterial (Fig. S4). Background subtractionmeasurements
were performed by measuring the ﬂuorescence intensity of antibodies above
supported lipid membranes containing no hapten-conjugated lipids (36).
RESULTS
Binding in bulk solution
In a ﬁrst set of experiments, binding constants for antibody-
hapten interactions were measured in bulk by the ﬂuores-
cence anisotropy technique. The fraction of bound hapten,
fB, was estimated as follows (45):
fB ¼ r  rFðr  rFÞ1RðrB  rÞ with R ¼
FB
FF
; (1)
where r is the observed anisotropy. On the other hand, rF and
rB are the anisotropies of the free and bound ligands, re-
spectively. The parameter, R, was introduced to correct for
changes in total ﬂuorescence intensity upon complex for-
mation (46). Its value is determined by the ratio of the
wavelength-integrated intensity of the free, FF, and bound,
FB, forms of the dye-conjugated antigen, as can be seen in
Eq. 1. The absorption of the samples was matched and kept
below 0.05 to avoid inner ﬁlter effects. The values of R were
found to be 0.68 for biotin/anti-biotin and 2.3 for DNP/anti-
DNP, respectively.
Experiments were performed with 1 nM of both B4F and
D5F. The antibody concentrations were varied. A Langmuir
adsorption model was then employed to determine the ap-
parent bulk equilibrium dissociation constant, KD(bulk):
KDðbulkÞ ¼ ½P½L=½PL; (2)
where [P], [L], and [PL] represent the concentrations of free
antibody, free antigen, and the antibody-antigen complex,
respectively. The total concentration of antigen in solution,
[L]tot, is
½Ltot ¼ ½L1 ½PL: (3)
From this relationship, the fractional binding, fB, of ligand
to the protein should be
fB ¼ ½PL½Ltot
¼ ½P
KDðbulkÞ1 ½P: (4)
The concentration of free antibody, [P], was calculated by
subtracting the bound antibody concentrations from the total
protein concentration (47). Nonspeciﬁc binding as well as a
correction term arising from the bound versus free ligand
concentrations was not taken into account. It should be noted,
however, that the calculation is still considered valid in this
case because the ligand concentration (1 nM) did not exceed
the measured KD(bulk) values (48). Moreover, nonspeciﬁc
IgG adsorption on the walls of the sample holder should be
minimal because plastic rather than glass cuvettes were em-
ployed (47,49).
Fig. 3 shows the binding isotherms for the a), biotin/anti-
biotin, and b), DNP/anti-DNP binding pairs. The KD(bulk)
values extracted from these data are equal to the concentra-
tion of free antibodies in solution at which half of the B4F and
D5F molecules are bound to their respective antibodies. At
25C, KD(bulk) was found to be 1.76 0.2 nM for biotin/anti-
biotin and 2.9 6 0.1 nM for DNP/anti-DNP, respectively.
These values are in good agreement with previous reports for
each hapten/antibody system (50,51). The data here are also
consistent with the notion that the ﬂuorescein and linker
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moieties do not signiﬁcantly inﬂuence the KD(bulk) mea-
surements. These results demonstrate that the intrinsic af-
ﬁnity of the two antibodies for their respective antigens in
bulk solution is nearly identical.
Binding at lipid membrane surfaces
As with bulk binding data, a Langmuir adsorption model was
employed for ﬁtting data at membrane interfaces. The as-
sociation of a free antibody in solution with an available
membrane-bound hapten, Ls, led to the formation of a
membrane-bound complex, PLs, which could be character-
ized by a ﬁrst dissociation constant, KD1:
KD1½PLs ¼ ½P½Ls: (5)
A key difference between Eq. 2 and Eq. 5 is the presence of
the subscript, s, which denotes the fact that the quantity is a
two-dimensional concentration and has units of mol/dm2.
Moreover, the antibody is bivalent so that the PLs complex
can rearrange on the surface and bind to a second hapten to
form PL2s:
KD2½PL2s ¼ ½PLs½Ls (6)
where KD2 is the second dissociation constant. The total
concentration of binding sites on the membrane surface, [S]s,
can be written as (36)
½Ss ¼
1
2
½Ls1
1
2
½PLs1 ½PL2s: (7)
It is assumed that the measured surface ﬂuorescence is
proportional to the surface protein concentration (36). There-
fore, the normalized surface ﬂuorescence can be written in
terms of a fractional surface coverage:
Fð½PÞ
Fð½NÞ ¼
½PLs1 ½PL2s
½Ss
¼ a½P
KD1 ½P; (8)
where F([P]) is the measured ﬂuorescence intensity when the
bulk concentration of labeled antibody is [P]. F([N]) is the
ﬂuorescence intensity when the membrane surface is com-
pletely saturated with dye-labeled antibodies. The parameter,
a, is a constant that varies between 0.5 and 1.0 and reﬂects
the degree of monovalent versus bivalent antibody binding
(36). Formally, its value is dependent upon KD2 as
a ¼ KD21 ½Ls
KD21 2½Ls
: (9)
Finally, the value of the overall apparent equilibrium disso-
ciation constant at the surface, KD, depends upon both KD1
and KD2:
KD ¼ KD1KD2
KD21 2½Ls
: (10)
Representative binding isotherms for anti-biotin and anti-
DNP antibodies are shown in Fig. 4. Measurements were
made with phospholipid membranes consisting of 5 mol % of
the ligand and 95 mol % POPC. It should be noted that the
concentration of a free antibody in solution, [P], was equal to
the applied concentration because the protein was continu-
ously ﬂowed through the microﬂuidic channels until equilib-
rium was established. The value of KD for biotin/anti-biotin
was 3.6 (61.1) nM. By striking contrast, DNP/anti-DNP
binding was much weaker. In this case KD was 2.0 (60.2)
mM. Such a result is remarkable because these binding con-
stants were nearly identical in bulk solution (Fig. 3). At
membrane interfaces, however, they differ by three orders of
magnitude.
FIGURE 3 Binding isotherms in bulk solution obtained
from ﬂuorescence anisotropy measurements. (A) B4F bind-
ing with anti-biotin antibody. (B) D5F binding with anti-
DNP antibody. Each data point represents the averaging of
three measurements.
FIGURE 4 Surface binding isotherms for (A) anti-biotin
antibody binding to 5 mol % biotin-cap-PE and (B) anti-
DNP antibody binding to 5 mol % DNP-cap-PE. All data
points represent the average of three independent runs. The
solid lines represent the best ﬁt of the data to simple
Langmuir adsorption isotherms.
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The KD values obtained in Fig. 4 should not be directly
compared with the KD(bulk) values obtained in Fig. 3. That is
because the antibody can bind bivalently at the lipid interface
and, therefore, the value of KD is dependent upon both the
ﬁrst and second dissociation constants (Eq. 10) (12,36,52).
Nevertheless, it should be pointed out that bivalent binding
only enhances binding for an IgG by;1 order of magnitude
at high ligand density (36).
It should be noted that the phosphate groups of biotin-cap-
PE and DNP-cap-PE were negatively charged (pK; 3) (53)
as well as the underlying glass support (54). The antibodies
employed in this study were also negatively charged at pH¼
7.2. The protein charges were experimentally conﬁrmed by
pressure-mediated capillary electrophoresis (55), which
showed that the anti-DNP and anti-biotin antibodies bore the
same charge. Therefore, electrostatic repulsion effects need to
be considered. Indeed, Leckband and co-workers have pre-
viously reported that substrate electrostatics can affect the
binding afﬁnity at interfaces (56). However, both the biotin-
cap-PE and DNP-cap-PE supported bilayer systems on glass
should bear the identical charge. Therefore, electrostatic re-
pulsion probably cannot account for the three order of mag-
nitude difference in binding for the DNP/anti-DNP system
relative to the biotin/anti-biotin system. Indeed, the changes in
binding afﬁnity noted by Leckband and co-workers were
rather modest (,1 order of magnitude) for relatively large
changes in surface and protein charge density.
Binding at PEG-coated surfaces
SUVs consisting of biotin-cap-PE (1 mol %) and varying
amounts of PEG5000-PE in POPC were prepared as described
in Materials and Methods. Surface binding measurements for
the biotin/anti-biotin system were performed by the same
procedures as described above. The abstracted KD values
versus PEG concentration are plotted in Fig. 5 A. Without
PEG in the membrane, KD was 3.6 6 0.2 nM but weakened
by an order of magnitude with just 0.2 mol % PEG5000-PE.
Moreover, the equilibrium dissociation constant continued to
weaken as the density of lipopolymer increased. In fact, the
KD value was well into the micromolar range at the highest
PEG5000-PE concentration (1.5 mol % PEG5000-PE).
The greatest change in the KD value occurred between 0.5
and 0.7 mol % lipopolymer. It is well known that PEG-PE
undergoes a structural transition from the mushroom to brush
state depending on its surface density. Kuhl et al. (57) and
Bianco-Peled et al. (58) have directly measured the polymer
thickness changes for this ﬁlm using neutron reﬂectivity.
PEG5000-PE (molecular mass ¼ 5000 Da) polymers exhibit
such transition around 0.5 mol % although it should be noted
that this transition is rather broad (59). These results appear to
indicate that the brush conformation is more effective than
the mushroom conformation at weakening the binding. Such
a result is consistent with the notion that polymer molecules
need to be pushed out of the way laterally for the IgG to bind
at the lipid membrane surface, which was predicted by
Szleifer (60) and Halperin (61). This is energetically less
costly in the more compressible mushroom state.
In addition to weakening the equilibrium dissociation
constant, the amount of IgG which can be bound at saturation
should also be affected by the density of lipopolymer in the
membrane. To demonstrate this, membranes containing be-
tween 0 and 1.5 mol % PEG5000-PE were challenged with a
saturation concentration of anti-biotin (20 mM). The data
clearly show that only about half as much IgG can be bound
in the presence of 1.5 mol % PEG5000-PE compared with the
lipopolymer-free case (Fig. 5 B). This result can be under-
stood on steric ground, as there is only a ﬁnite amount of
space for proteins to adsorb when PEG5000-PE is also present.
It should be noted that increasing the PEG-PE concentration
slightly increases the negative charge at the interface, although
the change is very small comparedwith the large chargedensity
on the underlying glass support (54). Therefore, the relative
increase in electrostatic repulsion between the surface and the
negatively charged antibodies again need to be considered. The
results of Leckband and co-workers, however, clearly show
that that one needs much larger changes in charge density such
as those caused by modulating pH to cause modest changes in
afﬁnity (56). Moreover, Kenworthy and co-workers note that
steric repulsion dominates over electrostatic effects for bilayers
containing PEG2000-PE and PEG5000-PE (62). Therefore, we
judge the steric effects to be dominant in the case here.
Binding of anti-DNP to DNP presented on a
PEG linker
In an effort to modulate the surface binding of DNP to anti-
DNP, the hapten moieties were conjugated to the end of
FIGURE 5 Binding between anti-biotin and biotin-cap-
PE (1 mol %) at PEG polymer (molecular weight 5000)
coated lipid membrane surfaces. (A) Changes in KD as a
function of PEG5000-PE concentration. All results are the
average of three independent measurements. (B) Compar-
ison of the relative ﬂuorescence intensity from bound anti-
biotin at saturation coverage ([IgG] ¼ 20 mM) with
varying surface densities of PEG5000-PE.
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NH2-PEG
2000-PE as described in the experimental section.
SUVs were elaborated with;1mol %DNP-PEG2000-PE and
varying concentrations of PEG2000-PE. The KD value for
the DNP-PEG2000-PE/anti-DNP system was obtained by the
same procedures described above. KD was found to be 21 6
10 nM for bilayers containing ;1 mol % DNP-PEG2000-PE
and no additional PEG2000-PE (Fig. 6 A). This value is two
orders of magnitude tighter than the value for DNP-cap-PE.
To verify that this enhancement in KD was due only to a
change in ligand presentation, a solution binding constant
measurement for DNP-PEG2000/anti-DNP was made in bulk
solution by ﬂuorescence quenching (12). The value ofKDwas
found to be 3.56 0.6 nM (Fig. S2), which is the same as the
value obtained in Fig. 3 B within experimental error. This
explicitly shows that the PEG linker does not signiﬁcantly
interfere with the equilibrium dissociation constant.
Additional control experiments were performed to test the
effect of the DNP-PEG2000-PE concentration on the binding
afﬁnity. The results showed that increasing the concentration
of the PEG ligand up to ﬁvefold did not show any change in
the measured KD value. Therefore, this system appears to be
insensitive to surface ligand density.
To test the inﬂuence of DNP-PEG2000-PE conformation
on binding afﬁnity, experiments were conducted by adding
PEG2000-PE to the membrane (up to 9 mol %), while holding
the DNP-PEG2000-PE concentration constant (Fig. 6 B). It is
well known that increasing the polymer density causes these
species to adopt amore brush-like conformation (57,58,63,64).
Again, no change was found in binding afﬁnity, which indi-
cates that the binding is also apparently insensitive to the
conformation of the polymer-conjugated DNP ligand. A ﬁnal
control was performed by repeating these measurements us-
ing a biotin-PEG2000-PE/anti-biotin system.Again, theKDvalue
was insensitive to ligand density and conformation (KD ¼
3.66 1.0 nM). It should be noted that the biotin-PEG2000-PE/
anti-biotin KD value is identical within experimental error to
the one for the biotin-cap-PE/anti-biotin system.
DISCUSSION
Effect of hapten density versus
ligand presentation
The results in Figs. 3–6 clearly demonstrate that protein-
ligand interactions at lipidmembrane interfaces can be strongly
affected by ligand presentation. By contrast, our laboratory has
previously reported results for the binding behavior of anti-
DNP to DNP-cap-PE in a lipid bilayer as a function of ligand
density (36). In that case, the apparent equilibrium dissociation
constant was found to be strengthened by only one order of
magnitude as the ligand density was increased from 0.1 to
5.0 mol %. Moreover, we have recently investigated the pen-
tavalent binding of cholera toxin to ganglioside GM1 as a
function of the glycolipid density (40). In that case the binding
was actually weakened by slightly less than one order of mag-
nitude by increasing the ligand density from 0.02 mol % GM1
to 10mol%GM1.This decrease occurredbecause ganglioside-
ganglioside interactions helped to inhibit ligand-protein bind-
ing. The results here suggest that ligand presentation is a more
effectivemethod than changes in ligand density formodulating
the thermodynamic properties of interfacial binding.
Lipophilicity
The KD(bulk) values for biotin/anti-biotin and DNP/anti-DNP
are virtually identical, yet the KD values for the same binding
pairs differed dramatically at the bilayer interface (Figs. 3 and
4). We postulate that the relative lipophilicity of the hapten
moieties is the origin of this dramatic difference. In fact, the
octanol-water partition coefﬁcient (log P) for DNP is 1.5 (65),
but it is only 0.11 for biotin (66). DNP is known to penetrate
the outer membrane of mitochondria and associate with the
innermembrane (67). Balakrishnan and co-workers suggested
that DNP haptens as well as other lipophilic molecules can
bury themselves into lipidmembranes via interactionswith the
aliphatic portions of the bilayer (14). Qualitative results from
their studies suggested that binding was stronger for gel phase
membranes than for bilayers in the liquid crystalline phase.
By contrast, the relatively hydrophilic biotin moiety should
largely prefer the aqueous phase. In fact, the ureido moiety,
(-NH-CO-NH-), of the 2-imidazolidone ring of biotin mole-
cules undergoes hydrogen-bonding interactions with biotin-
binding proteins such as avidin and streptavidin (68,69).
Therefore, biotin should probably also bind to water in aque-
ous solution and thereby be more available for IgG binding.
Screening of anti-biotin by PEG density
PEG-coated lipid membrane surfaces can inhibit the binding
of anti-biotin to surface-conjugated hapten moieties (Fig. 5).
FIGURE 6 (A) Anti-DNP binding to ;1 mol % DNP-
PEG2000-PE in a POPC membrane. The solid line repre-
sents the best ﬁt to simple Langmuir adsorption isotherms.
(B) Plot of Log (KD /[nM]) for ;1 mol % DNP-PEG
2000-
PE with varying concentrations of PEG2000-PE. All bind-
ing data were ﬁt to simple Langmuir isotherm. The data
points represent the average of three independent measure-
ments.
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Such an effect should be related to the types of mechanisms
that are normally thought to be involved in the repulsive
interaction between proteins and PEG ﬁlms. In fact, the in-
hibition depends on PEG surface density just as it does with
resistance to biofouling (70); i.e., increasing the surface
density clearly shows a marked effect at the onset of the
mushroom-to-brush transition. Szleifer (60,71) and Halperin
(61) have provided theoretical insights into such steric re-
pulsion mechanisms by modeling nonspeciﬁc protein ad-
sorption. According to Szleifer, the protein must displace the
polymer chains laterally to sit on the surface. This causes
conformational entropy losses for the polymer molecules as
well as protein-polymer repulsion but is offset by protein-
surface attractions (72).
Halperin predicted two possible nonspeciﬁc adsorption
mechanisms for proteins on PEG ﬁlms: an invasive mecha-
nism at the surface and a compressive mechanism at the outer
edge of the polymer brush. Small proteins penetrate the brush
conformation with a relatively low free energy penalty (in-
vasive mechanism). By contrast, large proteins indirectly
contact the surface by compressing the polymer brush
(compressive mechanism). Both Szleifer and Halperin pre-
dicted that the inhibition of protein adsorption is more pro-
nounced with increasing PEG density than with increasing
PEG chain length (61,71,73). These theoretical models are in
good agreement with our experimental results for speciﬁc
ligand-receptor interactions.
Effect of a PEG linker on DNP presentation
Our results clearly demonstrate that the KD value for the
DNP/anti-DNP system can be strongly modulated by ligand
presentation using a PEG tether. We found that the KD value
for the DNP/anti-DNP system in the presence of the PEG
tether was enhanced by two orders of magnitude at surfaces.
These results seem to indicate that the solution properties in
the environment immediately surrounding the ligand are
critical. The use of a long hydrophilic polymer tether above
the membrane almost certainly increases the partitioning of
the DNP into the aqueous phase. As noted above, the octanol-
water partition coefﬁcient for DNP is 1.5 (65). This implies
that DNP should favorably partition into the lipid bilayer
compared to the adjacent aqueous phase. When a PEG linker
is added, the DNP moiety instead must partition between the
polymer ﬁlm and the aqueous phase. Since the PEG layer is
not as hydrophobic as the lipid interface, a more equal par-
titioning should be expected. In fact, Longo and Szleifer
predicted that PEG polymer spacers increase the availability
of the ligand, attenuate lateral repulsions, and, thereby, in-
crease binding (28).
It should be noted that the equilibrium dissociation constant
for theDNP-PEG2000-PE/anti-DNP systemwas still one order
of magnitude weaker than for the biotin-PEG2000/anti-biotin
system at the membrane interface. Leckband and co-workers
reported that PEG interacts at least modestly well with non-
polar, hydrophobic groups (74). We, therefore, suggest that
theDNPmoiety probably still partitions to a signiﬁcant extent
into the hydrated PEG region in the system here.
Finally, it should be emphasized that the nanomolar
equilibrium dissociation constant with the PEG tether rep-
resents the strongest binding for anti-DNP to a membrane-
associated DNP for any method reported to date. By contrast,
the introduction of cholesterol to a bilayer was found to only
mildly enhance the binding constant (75). The use of short
PEG spacers such as (EO)2 or (EO)4 also had only a very
modest effect (76).
Glycocalix
The results presented here lead to a central question. How
does nature manipulate ligand presentation at a cell surface to
regulate ligand-receptor binding? For example, does the
cell’s glycocalix, which consists of a network of glycopro-
teins, glycolipids, and related sugar moieties, serve to mod-
ulate or completely screen aqueous proteins based on their
size? Moreover, are the equilibrium dissociation constants
for drug molecules to membrane proteins really signiﬁcantly
altered from bulk values by the presence of the glycocalix? It
is generally believed that the carbohydrate shell on the
plasma membrane leads to the stabilization of the structure of
the membrane via a variety of intra- and intermolecular
physical interactions (77). For drug molecules to bind target
proteins, however, they must also often initially interact with
membrane phospholipids (78). Some investigations suggest
that the composition of the lipid bilayer itself can affect drug
sensitivity (7,79). The results from the experiments here seem
to be consistent with the notion that this sensitivity may arise
from changes in the partitioning of the small molecule be-
tween the aqueous and lipid phases based upon hydropho-
bicity. This effect along with steric interactions may be the
dominant properties attenuating apparent in vivo binding
constants compared with those found in aqueous solution.
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